AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
This journal contains articles on developments in neurosurgical and neurological techniques affecting nursing procedures.
Set up an RSS feed
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Overview: hyperacute rt-PA stroke treatment. (recombinant tissue plasminogen activator)(Special Issue on rt-PA Stroke Treatment)
December 1, 1997... Introduction
Stroke is the third leading cause of death in the United States, being responsible for 150,000 mortalities annually. Approximately 550,000 new strokes occur every year, and there are an estimated 3,000,000 stroke...
Pathophysiology and mechanisms of acute ischemic stroke. (recombinant tissue plasminogen activator)(Special Issue on rt-PA Stroke Treatment)
December 1, 1997... Introduction
Stroke is a major health care problem; it is the third leading cause of death and the leading cause of major disability among adult Americans.[5] Stroke patients account for more than half of all neurological...
Code stroke: rapid transport, triage and treatment using rt-PA therapy.(recombinant tissue plasminogen activator)(includes protocol for acute ischemic stroke)(Special Issue on rt-PA Stroke Treatment)
December 1, 1997... Introduction
The recently published NINDS rt-PA Stroke Trial gives health care professionals the first treatment to limit or reverse the devastating effects of ischemic stroke.[8] in the trial, patients receiving recombinant tissue...
Nursing management of acute complications following rt-PA in acute ischemic stroke.(recombinant tissue plasminogen activator)(Special Issue on rt-PA Stroke Treatment)
December 1, 1997... Introduction
The NINDS rt-PA stroke trial was a randomized, double-blind, placebo-controlled study, which enrolled a total of 624 patients within three hours of onset of acute ischemic stroke (AIS). Overall, the results demonstrated...
Nursing care of acute stroke patients after receiving rt-PA therapy. (recombinant tissue plasminogen activator)(Special Issue on rt-PA Stroke Treatment)
December 1, 1997... Introduction
Once a patient is identified as a candidate for recombinant tissue plasminogen activator (rt-PA) and treatment is initiated, the focus of care shifts from screening and initial assessment to safety and prevention of...
Using the NIH stroke scale to assess stroke patients. (recombinant tissue plasminogen activator)(Special Issue on rt-PA Stroke Treatment)
December 1, 1997... Introduction
A 43 year-old woman is transported by emergency medical services (EMS) to the emergency department (ED). The paramedics noted her inability to move the left side of her body. Vital signs on arrival are blood pressure...
Education to improve stroke awareness and emergent response. (list of risk factors included)(related article includes continuing education test on rt-PA therapy)(Special Issue on rt-PA Stroke Treatment)
December 1, 1997... Introduction
Stroke is a leading cause of death and disability in the United States. It effects three million persons living with stroke, and touches one of every four families. Stroke costs 30 billion dollars annually in health care...